Affinia Therapeutics Secures FDA Orphan Drug Designation for Investigational BAG3 Cardiomyopathy Gene Therapy

As reported on Pharmaceutical Business Review, Affinia Therapeutics has been granted orphan drug designation by the US Food and Drug Administration (FDA) for AFTX-201, an experimental gene therapy being developed…

Continue Reading Affinia Therapeutics Secures FDA Orphan Drug Designation for Investigational BAG3 Cardiomyopathy Gene Therapy

Scientists Find Poly-coated Nanoparticles Plus Therapeutic Drugs Have a Potential as Cancer Treatment

As reported on Science Daily, scientists have combined polymer-coated nanoparticles with therapeutic drugs for cancer treatment, including treatment for ovarian cancer. The nanoparticles target tumors and subsequently release their payloads,…

Continue Reading Scientists Find Poly-coated Nanoparticles Plus Therapeutic Drugs Have a Potential as Cancer Treatment